Laura Schmitt

5PUBLICATIONS
17CO-AUTHORS
ChemotherapyMedical infection agents (incl. prions)Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
Inhibition of RNA polymerase II-activating CDK9 and CDK12/13, but not of cell cycle relevant CDKs, induces apoptosis by downregulating the short-lived Bcl-2 proteins Mcl1 and Bfl1/A1.

|Mar 09, 2024
Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2.

Laura Schmitt, Ilka Lechtenberg, Daniel Drießen

|Feb 27, 2024
From the Total Synthesis of Semi-Viriditoxin, Semi-Viriditoxic Acid and Dimeric Naphthopyranones to their Biological Activities in Burkitt B Cell Lymphoma.

Frederike Weber, Anja Weber, Laura Schmitt

|Nov 08, 2022
The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism.

Fabian Stuhldreier, Laura Schmitt, Thomas Lenz

|Mar 06, 2021
40 Years of Research on Polybrominated Diphenyl Ethers (PBDEs)-A Historical Overview and Newest Data of a Promising Anticancer Drug.

Laura Schmitt, Ilka Hinxlage, Pablo A Cea

Pageof 1

Frequent Collaborators

5 joint publications

Sebastian Wesselborg

3 joint publications

Ilka Lechtenberg

3 joint publications

Christoph Peter

3 joint publications

Björn Stork